TY - JOUR
T1 - Systematic Functional Analysis of PINK1 and PRKN Coding Variants
AU - Broadway, Benjamin J.
AU - Boneski, Paige K.
AU - Bredenberg, Jenny M.
AU - Kolicheski, Ana
AU - Hou, Xu
AU - Soto-Beasley, Alexandra I.
AU - Ross, Owen A.
AU - Springer, Wolfdieter
AU - Fiesel, Fabienne C.
N1 - Funding Information:
This study was funded in part by the Michael J. Fox Foundation for Parkinson’s Research (MJFF) (006883 [Legacy ID 15007] to WS). F.C.F. is supported by the Florida Department of Health—Ed and Ethel Moore Alzheimer’s Disease Research Program grant 22A07 and the MJFF. F.C.F. also received support from the American Parkinson Disease Association (APDA), the Mayo Clinic Younkin Scholar Program, and the Mayo Clinic Gerstner Family Career Development Award from the Mayo Clinic Center for Individualized Medicine (CIM) and the Center for Biomedical Discovery (CBD). W.S. is further supported by the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) [RF1 NS085070, R01 NS110085, and U54 NS110435], National Institute of Aging (NIA) [R56 AG062556], the Department of Defense Congressionally Directed Medical Research Programs (CDMRP) [W81XWH-17-1-0248], Mayo Clinic Foundation and the Mayo Clinic CBD. O.A.R. is supported in part by NIH [P50 NS072187, R01 NS078086, U54 NS100693], Department of Defense [W81XWH-17-1-0249], the ABF, the MJFF, the Little Family Foundation, and the CIM at Mayo Clinic. X.H. is supported by a pilot grant and a developmental project award from the Mayo Clinic Alzheimer Disease Research Center (ADRC) and a fellowship awarded by APDA.
Publisher Copyright:
© 2022 by the authors.
PY - 2022/8
Y1 - 2022/8
N2 - Loss of either PINK1 or PRKN causes an early onset Parkinson’s disease (PD) phenotype. Functionally, PINK1 and PRKN work together to mediate stress-activated mitochondrial quality control. Upon mitochondrial damage, PINK1, a ubiquitin kinase and PRKN, a ubiquitin ligase, decorate damaged organelles with phosphorylated ubiquitin for sequestration and degradation in lysosomes, a process known as mitophagy. While several genetic mutations are established to result in loss of mitophagy function, many others have not been extensively characterized and are of unknown significance. Here, we analyzed a set of twenty variants, ten in each gene, focusing on understudied variants mostly from the Parkinson’s progressive marker initiative, with sensitive assays to define potential functional deficits. Our results nominate specific rare genetic PINK1 and PRKN variants that cause loss of enzymatic function in line with a potential causative role for PD. Additionally, we identify several variants with intermediate phenotypes and follow up on two of them by gene editing midbrain-derived neuronal precursor cells. Thereof derived isogenic neurons show a stability defect of the rare PINK1 D525N mutation, while the common PINK1 Q115L substitution results in reduced kinase activity. Our strategy to analyze variants with sensitive functional readouts will help aid diagnostics and disease treatment in line with current genomic and therapeutic advances.
AB - Loss of either PINK1 or PRKN causes an early onset Parkinson’s disease (PD) phenotype. Functionally, PINK1 and PRKN work together to mediate stress-activated mitochondrial quality control. Upon mitochondrial damage, PINK1, a ubiquitin kinase and PRKN, a ubiquitin ligase, decorate damaged organelles with phosphorylated ubiquitin for sequestration and degradation in lysosomes, a process known as mitophagy. While several genetic mutations are established to result in loss of mitophagy function, many others have not been extensively characterized and are of unknown significance. Here, we analyzed a set of twenty variants, ten in each gene, focusing on understudied variants mostly from the Parkinson’s progressive marker initiative, with sensitive assays to define potential functional deficits. Our results nominate specific rare genetic PINK1 and PRKN variants that cause loss of enzymatic function in line with a potential causative role for PD. Additionally, we identify several variants with intermediate phenotypes and follow up on two of them by gene editing midbrain-derived neuronal precursor cells. Thereof derived isogenic neurons show a stability defect of the rare PINK1 D525N mutation, while the common PINK1 Q115L substitution results in reduced kinase activity. Our strategy to analyze variants with sensitive functional readouts will help aid diagnostics and disease treatment in line with current genomic and therapeutic advances.
KW - PD genes
KW - PINK1
KW - PRKN
KW - Parkin
KW - Parkinson
KW - mitophagy
KW - ubiquitin
UR - http://www.scopus.com/inward/record.url?scp=85136790670&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136790670&partnerID=8YFLogxK
U2 - 10.3390/cells11152426
DO - 10.3390/cells11152426
M3 - Article
AN - SCOPUS:85136790670
SN - 2073-4409
VL - 11
JO - Cells
JF - Cells
IS - 15
M1 - 2426
ER -